Drug intelligence / Profile preview

2'-deoxy-2'-fluoroguanosine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

2'-Deoxy-2'-fluoroguanosine is a synthetic nucleoside analog characterized by the substitution of a fluorine atom at the 2' position of the deoxyribose sugar ring of guanosine. It functions as a potent antiviral agent, demonstrating significant activity against a range of viruses, most notably influenza (A and B) and herpes simplex viruses (HSV-1 and HSV-2). The mechanism of action involves the intracellular phosphorylation of the compound to its active triphosphate form, which then competes with natural guanosine triphosphate (GTP) for incorporation into viral nucleic acids. This process leads to the inhibition of viral RNA-directed RNA polymerase (RdRp) in influenza viruses, effectively blocking viral transcription and replication. In herpesviruses, it similarly targets viral DNA polymerase. While it has been extensively studied in preclinical research for its antiviral properties, it is primarily utilized as a research tool and has not been developed into a commercial pharmaceutical product by a specific company.

Other names
2'-Fluoro-2'-deoxyguanosine2'-deoxy-2'-fluoro-D-guanosine2'-F-Guanosine2'-deoxy-2'-fluoro-guanosine
02

Targets

NS5B (Hepatitis C virus non-structural protein 5B (NS5B) RNA-dependent RNA polymerase)Influenza A virus RNA-directed RNA polymerase complexDNA polymerase family

Beyond the preview

Go deeper on 2'-deoxy-2'-fluoroguanosine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2'-deoxy-2'-fluoroguanosine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call